Topics and Speakers

Biomedical-Nanomedicine

Biomolecular Science and Engineering

Food, Health and Advanced Processing

Innovation in Food Processing

Advances in Bioengineering


Professor Thomas J Webster - Northeastern University, Boston USA

Professor Webster directs the Nanomedicine Laboratory which designs, synthesizes, and evaluates nanomaterials for various implant applications. Nanomaterials are central to the field of nanotechnology and are materials with one dimension less than 100 nm. Tissues investigated include bone, bladder, vascular, cartilage, dental, and the nervous system.

Dr. Thomas J. Webster’s degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995) and in biomedical engineering from Rensselaer Polytechnic Institute (M.S., 1997; Ph.D., 2000). He is currently the Department Chair and Professor of Chemical Engineering at Northeastern University in Boston. His research explores the use of nanotechnology in numerous applications. Specifically, his research addresses the design, synthesis, and evaluation of nanophase materials (that is, materials with fundamental length scales less than 100 nm) as more effective biomedical devices.

He has completed extensive studies on the use of nanophase materials to regenerate tissues and has graduated/supervised over 109 visiting faculty, clinical fellows, post-doctoral students, and thesis completing B.S., M.S., and Ph.D. students. To date, his lab group has generated over 9 textbooks, 48 book chapters, 306 invited presentations, at least 403 peer-reviewed literature articles, at least 567 conference presentations, and 32 provisional or full patents. His H index is 71. Some of these patents led to the formation of 9 companies. His research on nanomedicine has received attention in recent media publications including MSNBC (October 10, 2005), NBC Nightly News (May 14, 2007), PBS DragonFly TV (covered across the US during the winter, 2008), and ABC Nightly News via the Ivanhoe Medical Breakthrough Segment (covered across the US during the winters of 2008 and separate research segments in 2010 and 2011).

His work has been on display at the London and Boston Science Museums. He is the founding editor-in-chief of the International Journal of Nanomedicine (the first international journal in nanomedicine which in five years has achieved an impact factor of 4.97), serves on the editorial board of 15 additional journals, has helped to organize 22 conferences emphasizing nanotechnology in medicine, and has organized over 53 symposia at numerous conferences emphasizing biological interactions with nanomaterials. He also recently chaired the 2011 Annual Biomedical Engineering Society (BMES) Conference and has organized numerous symposia for AIChE, IEEE, MRS and ASME Annual Meetings. He has received numerous honors including, but not limited to: 2002, Biomedical Engineering Society Rita Schaffer Young Investigator Award; 2003, Outstanding Young Investigator Award Purdue University College of Engineering; 2005, American Association of Nanomedicine Young Investigator Award Finalist; 2005, Coulter Foundation Young Investigator Award; 2006, Fellow, American Association of Nanomedicine; 2010, Distinguished Lecturer in Nanomedicine, University of South Florida; 2011, Oustanding Leadership Award for the Biomedical Engineering Society (BMES); and Fellow, American Institute for Medical and Biological Engineering (AIMBE, representing the top 2% of all medical and biological engineers.

Residence: United States of America

Education: University of Pittsburgh (B.S., 1995) and in biomedical engineering from Rensselaer Polytechnic Institute.

Subject: Two Decades of Commercializing Nanotechnology for Medical Devices: Improving Medicine One Nano Step at a Time

---------------

Professor C James Kirkpatrick MD - Gutenberg University, Mainz Germany

Charles James Kirkpatrick has a triple doctorate in science and medicine (MD, PhD, DSc) from the Queen’s University of Belfast (N. Ireland) and is emeritus Professor of Pathology at the University Medical Center in Mainz, Germany. His academic appointments were at the University of Ulm, Manchester University, the RWTH Aachen (1987-1993) and the Johannes Gutenberg University (JGU) Mainz. He is a Fellow of the Royal College of Pathologists (FRCPath), London and has both honorary and visiting professorships in China, Singapore and Sweden. His principal research interests are in the fields of biomaterials in regenerative medicine, with special focus on human co-culture systems. During the past years his work has involved bone vascularization, the development of barrier models (e.g. air-blood barrier, blood-brain barrier) to study nanoparticle interactions with cellular systems, as well as co-culture models for upper respiratory tract regeneration.

He is author/coauthor of 504 publications in peer-reviewed journals, has given more than 490 invited lectures at scientific meetings worldwide and has an h-index of 55 (Web of Science) & 66 (Google Scholar). He has supervised 114 doctorate theses at two universities (Aachen, Mainz). He is a former President of both the German and European Society for Biomaterials. In 2008 he received the ESB’s George Winter Award, and in 2010 he was awarded the Chapman Medal from the Institute of Materials, Minerals & Mining, London, for “distinguished research in the field of biomedical materials”. In 2014 he received the TERMIS-EU Career Achievement Award (awarded at the TERMIS congress in Genova, Italy).

Residence: Germany

Education: MD, PhD, DSc, FRCPath, FBSE Graduate of the Queen's University of Belfast with B.Sc. (hons, 1. Class) in anatomy 1972, Ph.D. in experimental pathology 1977, M.B., B.Ch., B.A.O. in medicine 1978, M.D. (hons.) 1982 and D.Sc. 1992. M.D. (habil.) University of Ulm, Germany 1984

Subject: Bio-inspired systems for NanoMedicine: Cellular crosstalk as a basis for complex in vitro models

---------------

Associate Professor Sarah C Heilshorn - Stanford University USA

Heilshorn's interests include biomaterials in regenerative medicine, engineered proteins with novel assembly properties, microfluidics and photolithography of proteins, and synthesis of materials to influence stem cell differentiation. Current projects include tissue engineering for spinal cord and blood vessel regeneration, designing injectable materials for use in stem cell therapies, and the design of microfluidic devices to study the directed migration of cells (i.e., chemotaxis).

Residence: United States of America

Education: PhD, Caltech, Chemical Engineering (2004)
MS, Caltech, Chemical Engineering (2000)
BS, Georgia Tech, Chemical Engineering (1998)

Subject: Designing Medical Materials through Protein Engineering

---------------

Associate Professor Yunzhi Peter Yang - Stanford University USA

Yunzhi “Peter” Yang, Ph.D., Associate Professor with tenure of Departments of Orthopedic Surgery, (by courtesy) Materials Science and Engineering, and Bioengineering at Stanford University. He earned a doctorate in biomedical engineering in 1997, M.E. in 1995 and B.S. in 1992 in inorganic materials from Sichuan University in Chengdu, China. Then he has completed two postdoctoral fellowships, first in China in 1999, then at the University of Texas Dental School in San Antonio in 2003. Most recently, he was an Assistant Professor at the University of Texas Health Science Center at Houston, and adjunct Assistant Professor of at Rice University and The University of Texas at Austin. Before that, he was an Assistant Professor in the University of Tennessee’s School of Biomedical Engineering and Imaging, and adjunct Assistant Professor at the University of Memphis.

Yang’s research interests are in the areas of bio-inspired biomaterials, medical devices, and approaches for re-creating a suitable microenvironment for cell growth and tissue regeneration, including enabling technology for musculoskeletal tissue regeneration, nanotechnology for implant devices, and novel biomaterials for cancer treatment. He has pioneered on functionally graded biomaterials for bone and tendon regeneration, and vascularized constructs with biomimetic complexity. One of his recent interests is in the area of 3D bioprinting. He has received numerous research and teaching awards including the March of Dimes Birth Defect Foundation Award, the Wallace H. Coulter Foundation Award, and the NIH Star Award. Yang’s publications include 96 peer-reviewed journal papers, 11 book chapters, 18 peer-reviewed proceeding papers and 164 conference abstracts. He has eight U.S. and international patents and licensed two technologies. He also serves on four prestigious journal editorial boards.

Residence: United States of America

Education: Postdoctoral Fellow, University of Texas Health Science Center at San Antonio, San Antonio, TX, Biomaterials (2003)
Postdoctoral Fellow, West China University of Medical Sciences, Chengdu, China, Biomaterials (1999)
Ph.D., Sichuan University, Chengdu, China, Biomedical Engineering (1997)
M.E., Sichuan University, Chengdu, China, Inorganic Materials (1995)
B.S., Sichuan University, Chengdu, China, Inorganic Materials (1992)

Subject: Bio-inspired approaches for musculoskeletal tissue engineering

---------------

Professor Patrizia Perego - University of Genoa, Italy

Patrizia Perego is Professor of Chemical Plants at the Department of Civil, Chemical and Environmental Engineering, and Deputy Dean of the Polytechnic School at the University of Genoa (Italy). She serves as a member of the Groups of Experts of Evaluation at the Italian Agency for the Evaluation of Universities and Research Institutions (ANVUR). In addition, she is cofounder and Vice President of the Research Center of Biologically Inspired Engineering in Vascular Medicine and Longevity (BELONG) at the University of Genoa, a joint centre with the School of Medicine where innovative and functionalized biomaterials are investigated to develop new biodegradable vascular prosthesis and hydrogel-based wound dressing for chronic wounds management. She is also member of the Steering Committee of Sustainable Engineering & Architecture – IAS School of Excellence of Genova University (ISSUGE).

She has authored over 130 peer-reviewed journal articles and has been an invited speaker to several conferences. She has strong collaborative research with national/ international universities and industries. Her research focuses on nutraceutical and functional food development, valorization of food industry residues, technologies for food preservation, industrial process optimization, production and characterization of probiotics and encapsulation of bioactive compounds, as well as the aforementioned engineered biomaterials.

Residence: Italy

Education: PhD degree in Materials Engineering from the Milan Polytechnic (1987)
Degree in Science & Food Technology, Milan University (1982).

Subject: Green extraction and encapsulation of bioactive compounds for food and biomedical applications

---------------

Professor Kwang Leong Choy - University College, London UK

Professor Kwang-Leong Choy (DSc, FIMMM, FRSC) and her team perform pioneering research into novel, sustainable, and cost-effective processing of nanostructured thin films and thick coatings using non-vacuum and environmentally friendly Chemical Vapour Deposition (CVD) based methods, characterised by unique nanocrystalline microstructure and superior properties for energy and functional applications. She has over 25 years experience in surface coating and nanomaterials. She has authored over 200 peer-reviewed publications, including 2 books and 20 patents related to CVD based nanoparticles, nanowires, nanostructured ceramic and composite thin and thick films. She has given over 100 keynote/invited lectures. Professor Choy obtained her D.Phil. in Materials Science from the University of Oxford, where she was awarded the Hetherington Prize and Oxford Metallurgical Society Award. Her pioneering on the Electrostatic Spray Assisted Vapour Deposition has led to the Grunfeld Medal and Prize from Institute of Materials (UK).

Over the past four years, Professor Choy’s work has led to her participation in numerous multimillion pounds worth of research programmes. These include EU, EPSRC and government flagship grants, as well as research contracts and collaboration. She has been the international expert reviewer.She has been awarded Guest Professorships at the University of Uppsala (2001/03), Ningbo Institute of Materials Technology and Engineering (NIMTE, 2010/2012), and Chinese Academy of Sciences (CAS) Visiting Professorship for Senior International Scientist (2011/2013). Professor Choy is now a Director of UCL Institute for Materials Discovery and Professor of Materials Discovery at University College London since February 2014 to lead a multidisciplinary research centre to integrate fundamental chemistry, physics, materials, engineering and biological principles across the disciplines to create new opportunities in materials creation, discovery and exploitation for the development in clean energy, nanotechnology, engineering and biomedicine technologies.

Residence: United Kingdom

Subject: Nanostructured biomaterials for healthcare and biomedical applications

---------------

Professor Hua Wei - Lanzhou University, China

Dr. Hua Wei is a professor in the College of Chemistry and Chemical Engineering at Lanzhou University, China. He received his Ph.D. degree in Polymer Science in 2009 from Wuhan University, China, and then joined the University of Sydney as a postdoctoral fellow in 2010. He then worked as a senior fellow in the Department of Bioengineering at the University of Washington for 3 years before joining Lanzhou University. His research interests include the controlled synthesis and self-assembly of smart polymers and their applications for drug and gene delivery.

Residence: China

Subject: Sunflower Polymer for Targeted Drug Delivery

---------------

Associate Professor Ken Morison

Ken Morison is a graduate of chemical engineering from the University of Canterbury. After receiving a PhD specialising in process control from Imperial College London, he worked for eight years in the New Zealand dairy industry. Since 1993 he has been a senior lecturer and now associate professor with the Department of Chemical and Process Engineering, University of Canterbury. He is a Fellow of the Institution of Chemical Engineers, a Fellow of the NZ Institute of Food Science and Technology, and Editor-in-Chief (Food) of the IChemE journal Food and Bio-products Processing.

Residence: New Zealand

Subject: Specialised process engineering in the dairy industry: state of the art and possible future directions.

---------------

Professor Elmira Arab-Tehrany

Professor Elmira Arab-Tehrany is a Professor at Lorraine University, team leader in nano-vectorisation. She obtained her Bachelor in food science and engineering (1999), her Master in biotechnology (2001) and her PhD on biotechnology and food science (2005). She obtained her promotion in academic rank to Associate Professor at Lorraine University in 2012 and to Full Professor in 2015. She has been an international visiting fellow in Harvard Medical School and Massachusetts Institute of Technology (MIT). Since 2009 she has been a member of the expert committee at the French Agency for food safety since 2009, expert of scientific projects for Romanian and Poland Governments. She has co-authored more than 100 publications and has been invited speakers for several conferences.

Her research focuses on the development of nano-vector, encapsulation of various active molecules and multiscale physico-chemical characterization of active molecules. She has also expertise in green technologies for extraction of active molecules from food wastes.

Residence: France

Subject: Advanced micro-nano for drug delivery

---------------

Professor Amir Ghaem-Maghami

Amir Ghaem-Maghami is a Professor of Immunology & Immuno-bioengineering at the Faculty of Medicine and Health Sciences, University of Nottingham, United Kingdom. He obtained his MD (1996) before studying for a PhD in Immunology (2002) at the University of Nottingham. After working as a research fellow in Leicester and Nottingham Universities, investigating the role of antigen presenting cells in infectious and allergic diseases, he was appointed as a Lecturer at the University of Nottingham in 2006 followed by promotion to Associate Professor (2011) and Professor (2014).
Since 2007 he has been successful in obtaining in excess £15M funding from UK and international funding bodies as principle and co-investigator to pursue his research interests in 3 main areas: 1- Role of antigen presenting and epithelial cells in host-environment interaction 2- Immune modulation through surface engineering and 3- Bioengineering of immuno-competent tissue models as platforms for disease modelling and testing new drugs.

Over the years his group’s work in the area of innate immune recognition and allergic sensitization has led to many novel findings in the field. His more recent activities in immune modulation through surface engineering are aimed at developing ‘immune instructive’ materials with applications in drug/vaccine delivery and implantable biomedical devices. Amir is a Follow of UK Higher Education Academy and member of various national and international research funding panels.

Residence: England

Subject: Immune-instructive materials for medical applications

---------------

Professor Jimmy Yun, FTSE

Jimmy Yun is a professor with the University of New South Wales (UNSW), School of Chemical Engineering; and also a professor with the Beijing University of Chemical Technology (BUCT), Changzhou Advanced Materials Institute. Besides, he is a Fellow of the Australian Academy of Technological Sciences and Engineering, an elite member of the prestigious China National 1000Plan Program (Qianren Jihua), as well as an elite member of the Jiangsu Province Innovation and Entrepreneurial Program (Shuangchuang Tuandui), China.
Jimmy was graduated from the UNSW with Bachelor of Engineering in 1988, and PhD in 1993. After a stint of early careers in research development and industries in Japan, USA, Australia and Singapore, he eventually established his entrepreneur path in Singapore where he was the founder and CEO of Nanomaterials Technology Pte Ltd between 2000 and 2012.

He provided specialized R&D services to some the most influential global pharmaceutical and specialty chemicals companies. These pharmaceutical companies include GSK, Schering Plough, Johnson & Johnson, Novo Nordisk and Huabei Pharmaceutical Company etc., and specialty chemicals companies include BASF, 3M, Evoniks, Nitto Denko and Sinopec etc. The development areas, with more than 30 patents, covered advanced drug delivery system, particle system design, advanced environmental coating, and polymer nano-composite etc.

In addition to his current research work in UNSW and BUCT on advanced materials development and process intensification, Jimmy has also started another new company since 2015 in Changzhou, Jiangsu Province, China, focusing on advanced chemical product development with an objective to upgrading the technology level of the local manufacturing industries.

Residence: Australia / China

Subject: TBA

---------------

Professor Brent R. Young

Professor Brent R Young is currently a director of industrial information and control centre, Head of Chemical and Material Engineering Department (since 2012) and Chair of Food and Health Programme (since 2011) at The University of Auckland. Prior to this position he was at University of Technology, Sydney, Australia from 1991-1998 and University of Calgary, Canada from 1998 until 2005. He completed his BS and PhD in Chemical and Process Engineering from the University of Canterbury, New Zealand. He has received several awards (e.g. Engineers Australia John A Brodie Medallist 2008 and 2009 and also Caltex Australasian Award of Excellence in Chemical Engineering (Teaching) 2014). He was a Fellow of the Institution of Chemical Engineers UK, 2006, Fellow of the Institution of Professional Engineers NZ, 2014.

Residence: New Zealand

Subject: Advanced process systems engineering and biotechnology for food processing – a New Zealand perspective

---------------

Professor Domenico Palombo MD

Domenico Palombo, MD, is Full Professor in Vascular Surgery at the University of Genoa (Italy), Department of Surgical and Integrated Diagnostic Sciences. He authored over 90 international scientific papers and several book chapters. He has a strong collaboration with many universities and companies. In parallel to the daily surgical activity, he carried out multidisciplinary studies, aimed to investigate the molecular mechanisms underlying the progression of vascular diseases and to identify new approaches for treatment and prevention of these diseases. He is the founder of the first Vascular Tissue Bank in Italy, with institutional recognition (Genoa Vascular Tissue Bank), designed for the collection of blood and tissue samples from patients with vascular disease.

He is the Director of the Vascular Surgery Specialization School and former Coordinator of PhD course in Clinical and Experimental Vascular Biology and Surgery, also actively involved in teaching vascular surgery courses.
He is cofounder and President of the Research Centre of Biologically Inspired Engineering in Vascular Medicine and Longevity (BELONG) at the University of Genoa, a joint centre with the Polytechnic School where innovative and functionalized biomaterials are investigated to develop new biodegradable vascular prosthesis. He is member of the “Académie Nationale de Medecine”, “Académie de Chirurgie”, “Romanian Academy of Sciences”, past president of the Italian Society of Vascular Surgery (SICVE) and of the European Society of Cardiovascular and Endovascular Surgery (ESCVS).

Residence: Italy

Subject: Bioabsorbable functinalized small diameter vascular prosthesis: a surgeon perspective.

---------------

Professor Jennie Brand-Miller (AM, PhD, FAIFST, FNSA, MAICD)

Professor Jennie Brand-Miller holds a Personal Chair in Human Nutrition in the Boden Institute of Obesity, Nutrition, Exercise and Eating Disorders and the School of Molecular Bioscience, at the University of Sydney. She studied food science and technology before obtaining a doctorate in nutrition at the University of New South Wales.
She is recognised around the world for her work on carbohydrates and the glycemic index (or GI) of foods, with almost 300 scientific publications. She received the 2003 Clunies Ross Medal for contributions to science and technology in Australia. Her books under the series title “Low GI Diet” (Formerly The New Glucose Revolution) have made the GI a household word and sold over 3.5 million copies worldwide in 12 languages. She is a past-President of the Nutrition Society of Australia, immediate-past Chair of the National Committee for Nutrition of the Australian Academy of Science, and President of the Glycemic Index Foundation Ltd, a not-for-profit health promotion charity that administers a food symbol program for consumers in partnership with the JDRF (Australia).

She was a finalist in the 2006 Australian of the Year Award, and her books have sold millions of copies around the world. She was also recently made a Member (AM) in the General Division of the Order of Australia for service to education in the field of human nutrition as a researcher and academic, and as a supporter of people with a hearing impairment.
Jennie's research interests focus on all aspects of carbohydrates including diet and diabetes, the glycemic index and insulin resistance, lactose intolerance and oligosaccharides in infant nutrition.

Residence: Australia

Subject: Carbohydrates: consumer and industry responses to dietary recommendations.

---------------

Professor Jason Stokes

Jason Stokes is Professor and Director of Research in School of Chemical Engineering at The University of Queensland (UQ). His formal qualifications include a Bachelor of Engineering (Chemical) and PhD from The University of Melbourne, Australia. Prior to joining in 2008, he spent 10 years as a research scientist at Unilever’s Corporate Research laboratory in the United Kingdom.
Jason's core interest at UQ is in the multi-scale deformation of complex fluids and soft materials, which spans the fields of soft matter rheology and tribology, incorporating aqueous lubrication, microgels, biopolymers, nanocellulose, colloids and surfaces. The research is of a strategic nature that has applications in diverse areas such as food oral processing and sensory science, food structure design and engineering, plant cell wall micromechanics, biolubrication and biomimetics, and high pressure high temperature fluids for enhanced geothermal systems.

His rheology, lubrication and Biointerfaces laboratory supports ca. 20 researchers through funding from companies based nationally and internationally as well as ARC grants. He is a Chief Investigator on the ARC ITTC Agents of Change: Transforming the food industry for Australia, Asia and beyond, and an Associate Investigator in ARC Centre of Excellence of Plant Cell Walls.
Jason is currently a consultant for several international and national food companies, and is on the experts’ advisory panel for a New Zealand Primary Growth Partnership in Food Structure Design. He was awarded a UQ Partners in Research Excellence Award in 2014 for his successful collaborations with PepsiCo USA and the British Society of Rheology Annual Award 2013.

Residence: Australia

Subject: Towards rational food structure design: soft particles, rheology, tribology and biointerfaces

---------------

Ashley Brinson

Jonathan Ashley Brinson is the Warren Centre’s Executive Director having joined the organisation in July 2014.
Ashley has a broad range of experience across the technology and innovation spectrum and over 25 years’ experience in chemical engineering. Ashley is an inventor, named on five US patents in chemical engineering design.

With extensive experience in the silicon industry, Ashley has designed, built and managed large scale industrial plants in the US, UK and China. Ashley led cutting-edge robotic solar energy programs in China, Korea, California and Europe prior to coming to Australia to further his knowledge of intellectual property at the University of Sydney.

Ashley is well versed in clean energy, manufacturing, construction, chemical engineering, project management, stakeholder engagement and transformational leadership. Ashley is a passionate advocate for Australian innovation and the economic opportunities related to growing demand from Asia.

Ashley holds a Bachelor of Chemical Engineering from the Georgia Institute of Technology, an MBA from Rutgers University New Jersey and a Juris Doctor from the University of Sydney Law School.

Residence: Australia

Subject: The future of chemical Engineering in green synthesis, biomedical and health technology advances.

---------------

Scientia Professor J. Justin Gooding

Scientia Professor Justin Gooding graduated with a B.Sc. (Hons) from Melbourne University before spending two years working for ICI Research on explosives. He then returned to University obtaining a D.Phil. from the University of Oxford and received post-doctoral training at the Institute of Biotechnology in Cambridge University. He returned to Australia in 1997 as a Vice-Chancellor’s Post-Doctoral Research Fellow at the University of New South Wales (UNSW). He was promoted to full professor in 2006. He was one of the recipients of a 2004 NSW Young Tall Poppy award, a 2005 Alexander von Humboldt Fellowship, the 2007 RACI Lloyd Smythe Medal for Analytical Chemistry, the 2009 Eureka Prize for Scientific Research, the RACI 2011 H.G. Smith Medal for contributions to chemistry, the 2012 RACI R.H. Stokes Medal for electrochemical research, the 2012 Royal Society of Chemistry Australasian Lecturer, the 2013 NSW Science and Engineering Award for Emerging Research and the 2016 Faraday Medal of the Royal Society of Chemistry Electrochemistry Division.

In 2016 he was inducted as a Fellow of the Australian Academy of Science. Between 2010-2014 he was an ARC Professorial Fellow and is currently an ARC Australian Laureate Fellow and the co-director of the Australian Centre for NanoMedicine. He is also editor-in-chief of the journal ACS Sensors. He leads a research team of 42 people interested in surface modification and nanotechnology for biosensors, biomaterials, electron transfer and medical applications.

Residence: Australia

Subject: TBC

---------------

Dr Amir R. Aref

Dr. Amir R. Aref, is a staff scientist at the Dana-Farber Cancer Institute in the Belfer Center, made the important discovery in that it is possible to culture primary tumors in a novel 3D microfluidic system, by digesting them with collagenase and capturing spheroids that are composed of a mixture of tumor and immune cells. In addition, he has demonstrated the ability to treat these tumor spheroids with small molecule inhibitors and measure cytokine responses by collecting conditioned media from the device. This innovative technology is a major advance upon traditional 2D cell line culture and even organoid systems, which require time to establish and lack the immune microenvironment.

Residence: United States of America

Subject: Screening therapeutic anti-cancer agents in a three-dimensional microenvironment

---------------

Professor Greg Leslie

Greg is a Professor of Chemical Engineering and the director of the UNESCO Centre for Membrane Science and Technology at the University of New South Wales, Australia. Prior to joining UNSW Australia, he worked in the public and private sector on water treatment, reuse and desalination projects in Australia, New Zealand, Singapore, Hong Kong and the United States. He has served on the World Health Organisation Technical Committee that developed guidelines for desalination, the Water Issue Committee for the Australian National Health and Medical Research Council and the Independent Advisory Panel for the Orange County Groundwater Replenishment Project.

Residence: Australia

Subject: Improving process efficiency in broiler abattoirs without compromising safety or sustainability through water and energy recovery

---------------

Professor Sheng-Ce Tao

Dr. Sheng-Ce Tao is Professor of the Shanghai Center for Systems Biomedicine and Shanghai Jiao Tong University. He received his bachelor's degree (1997) in microbiology from Shandong University and his master's degree (2000) in molecular biology and biochemistry from Wuhan Institute of Virology, Chinese Academy of Sciences. In 2004 he received his Ph. D. from Tsinghua University under the supervision of Professor Jing Cheng, a pioneer of microarray technology in China and an academician of Chinese Academy of Engineering. Prior to coming to Shanghai Jiao Tong University, he was a post-doctoral fellow in the lab of Dr. Heng Zhu, associate professor of Johns Hopkins University. Dr. Tao has excellent scientific achievements, which include: 1) >50 scientific papers published in Nature Biotechnology, PNAS, eLIFE and so on; 2) 8 book chapters; 3) 20 issued patents. The two major directions in Dr. Tao’s lab are: 1) Protein microarray platform development and cutting-edge protein microarray related technology development; 2) Mycobacterium Tuberculosis systems biology.

The researchers in his group are supported by a variety of grants, which include 973, 863 and the National Natural Science Foundation of China. Dr. Tao is a renowned scientist in the field of protein microarray technology. He is now on the editorial board of Proteomics, and is the committee member of Chinese Biochip Association, Chinese Proteomics Association and Chinese Glycobiology Association.

Residence: China

Subject: Microarrays for GMO monitoring and cancer biomarker discovery

---------------

Professor Ping Xu

Dr Ping Xu is a distinguished professor of microbiology, biomolecular engineering and biochemical engineering as the deputy director of State Key Lab of Microbial Metabolism at Shanghai Jiao Tong University (SJTU). Dr. Xu has authored and co-authored over 220 research articles and over 50 issued and pending patent applications with several being licensed by industry. In addition, he has given over 100 of plenary, keynote or invited lectures in international meetings, universities, industries, and research institutes. Dr. Xu received numerous research and teaching awards and honors, such as Winner of Young Asian Biotechnologist Prize of the Society for Biotechnology Japan (2007), Distinguished Professor of “Hundred Talents Program” of Chinese Academy of Sciences (2005) and Fellow of the American Institute of Medical and Biological Engineering (AIMBE) (2014).

He has been elected a member of the US National Academy of Inventors (NAI). Dr. Xu serves as the consultant for over 10 companies, and serves as an editor (academic member) for a Nature journal Scientific Reports. His primary research interests are in the seminal discovery of useful bacteria and using metabolic engineering for agricultural, biotechnological, clean-environmental engineering and waste treatment applications.

Residence: China

Subject: Mimicking natural pathways for de novo biosynthesis of high-value added chemicals in bacteria

---------------

Dr Nihal Engin Vrana

Dr Nihal Engin Vrana is a fundamental research manager of prodip medical in France. He obtained his PhD in 2009 from Dublin City University as a Marie Curie ESR fellow. He holds an M.Sc. in Biotechnology and B.Sc. in Biology (both from Middle East Technical University, where he also studied Civil Engineering). His major research interests are titanium implants, immune responses to implants, real-time monitoring of implants, tissue engineering, cell encapsulation and cell biomaterials interactions. He currently coordinates the FP7 project Immodgel. He has published 29 articles in peer-reviewed academic journals, 4 book chapters and holds 2 European patents. His awards include Parlar Foundation Thesis of the Year (2006), ESB Translational Research award (2011) and 2nd Aegean R&D Patent competition 1st place award (2012).

Residence: France

Subject: Smart, Hybrid Implants: Methods to Establish Communication with the Host forImplantable Devices

---------------

Dr Mirjana Prica

Mirjana was appointed Managing Director of Food Innovation Australia Limited in July 2013, bringing a wealth of knowledge and experience in general management, business development and project management. She has over 17 years R&D project management experience of food, water, ceramic and mineral concepts and holds more than 10 years’ experience in business development and strategy for the food and agricultural sectors. After completing her MBA in 1991, Mirjana joined George Weston Foods (GWF), part of the Associated British Foods Group, to work in business development and technology transfer both in Australia and overseas. During this time she helped to establish a global feed ingredients business for the group. More recently she oversaw GWFs analytical services business, focusing on areas of food, cereals and related products.

Mirjana is a business-science post-graduate from University of Melbourne and has worked as a senior research scientist and lecturer at Keele University in the UK. She also spent part of her career as a scientist at Food Science Australia (CSIRO).

Residence: Australia

Subject: Celebrating Australian Food and Agribusiness Innovations

---------------

Professor Anthony Cunningham

AO, MD, M.B.B.S.,B. Med. Sci.(Hons), F.A.A.H.M.S., F.R.A.C.P., F.R.C.P.A., F.A.S.M.
Executive Director, The Westmead Institute for Medical Research and the Institute's Centre for Virus Research
Professor of Research Medicine, Sydney Medical School
Sub-Dean (Research), Westmead Clinical School

Professor Anthony (Tony) Cunningham, AO,FAHMS is an infectious diseases physician, clinical virologist and scientist, internationally renowned for his research on the immunobiology of HIV and herpesviruses, his work on vaccine and microbicide development, and as an antivirals expert. He is the Director of the Australian Centre for HIV and Hepatitis Virology Research (ACH2), a Commonwealth Government-funded institute that aims combat the impact of HIV and hepatitis in Australia and the Asia-Pacific region by bringing together basic researchers with translational scientists and physicians. Professor Cunningham has previously worked at Stanford University, USA, built up the State Reference Laboratory in Virology at and established a state reference HIV laboratory at Westmead Hospital in the mid 1980s before assuming directorship of WMI in 1996. He has generated many key discoveries relating to HIV.

His research has been instrumental in defining HIV interactions with host immune cells including dendritic cells (DCs), the initial target in the anogenital mucosa, and macrophages (the virus reservoir), and the process of virus trafficking to the final T cell target. His research aims to develop a treatment (e.g. topical antiviral/microbicide) that acts at the source of infection to prevent the spread of HIV. His team also has made key contributions to human immunology and neurobiology of Herpes simplex virus (HSV), leading to the development and trialing by GSK of a partly successful candidate HSV vaccine and recently, a highly efficacious vaccine for Herpes zoster.

Professor Cunningham serves on numerous international expert panels on HIV/HSV, antivirals and vaccines and as a member of the Australian Centre for Vaccine Development Scientific Advisory Committee. In 2010 he was awarded Officer of the Order of Australia (AO) for ‘service to medicine, particularly in the field of viral research and through the development and leadership of medical and biomedical research’.

Residence: Australia

Subject: TBA

---------------

Dr Qihan Dong

Dr Qihan Dong received his PhD in 1992 at the University of Sydney. He continued as a Fogarty Fellow at the National Institutes of Health, USA. On returning to Sydney in 1996, he was appointed as the Head of the Cancer Biology Group. Currently, he is an Associate Professor at the Western Sydney University and the University of Sydney. He has 72 publications and 2,823 citations. He is the first or corresponding author on 70% of them.

Residence: Australia

Subject: Impeding cell cycle re-entry of quiescent prostate cancer cells by compounds isolated from edible fruits and Chinese Herb Medicine

 

---------------

Dr Nasim Annabi

Dr. Annabi is an Assistant Professor at Northeastern University, as well as a lecturer at the Harvard-MIT’s Division of Health Sciences and Technology, and Brigham and Women’s Hospital at Harvard University. Her research involves the development of advanced biomaterials for biomedical applications. Dr. Annabi’s contributions appear in over 55 journal articles, 7 book chapters, over 75 abstracts, and 5 patent/disclosure applications. As of July 2016, she has been cited over 2300 times with an h-index of 25 and has given more than 30 invited seminars and keynote lectures.
Her interdisciplinary research has been recognized by several national and international awards and grants including the American Heart Association Scientific Development Award, the Interdisciplinary Research Seed Grants (FY17 TIER 1), the Bright Futures Award at Harvard University, the Australian Prestigious Endeavour Award, and the National Health and Medical Research Council Early Career Fellowship to name a few.

Residence: United States of America

Subject: Microengineered Hydrogels for Tissue Regeneration and Surgical Applications

---------------

Professor Liping Zhao

Professor Liping ZHAO is a distinguished professor of microbiology at School of Life Sciences and Biotechnology, Shanghai Jiao Tong University. He is a senior editor of the ISME Journal and a fellow of American Academy of Microbiology.

Liping has contributed significantly to the understanding of the causative role of the gut microbiota in obesity and related metabolic diseases. Using the logic of Koch’s postulates as a conceptual framework for demonstrating the etiological role of specific members of the gut microbiota in obesity, he showed that one endotoxin-producing opportunistic pathogen isolated from the gut of a morbidly obese volunteer causes obesity in germfree mice. He shows that traditional Chinese medicinal food plants can alleviate obesity and diabetes with gut microbiota as a primary target, opening new avenues for managing the devastating epidemic of metabolic diseases. SCIENCE magazine featured a story on how he combines traditional Chinese medicine and gut microbiota studies to understand and fight obesity (Science 326: 1248).

Residence: China

Subject: Gut microbiome: a new target for managing human metabolic health

---------------

Dr Nima Yazdanpanah

Dr Nima Yazdanpanah is a research associate at the MIT Department of Chemical Engineering, and a research scientist at MIT-Novartis Center for Continuous Manufacturing. He was recently appointed by the FDA as a member of an expert team for advancement of emerging technology to modernize pharmaceutical manufacturing. In 2013 he received his PhD in Chemical and Biomolecular Engineering from The University of Sydney, before joining MIT for his postdoctoral research position with Trout and Myerson labs. His area of research covers process engineering, molecular interactions study, nucleation and crystallization, mathematical modelling, multi-scale system control, and particle engineering. He has developed several novel techniques with emerging technologies for advancement of industry, such as his newest work on 3D printed drugs.
He has received national and international awards, including the Australia Endeavour Award and Engineers Australia Innovation Award. He has worked for six years in industry for R&D and Process Design sections. He is a senior member of American Institute of Chemical Engineering (AIChE). He serves on several review panels and advisory committees.

Residence: United States of America

Subject: Continuous manufacturing in bioprocessing, pharmaceutical and biopharmaceutical industries

---------------

Dr Neil Wilson

Neil is a postdoctoral research fellow in the Sydney School of Agriculture, specialising in the molecular biology and ecology of agriculturally relevant microorganisms. He is involved in several research projects relevant to the food industry, including the recently funded ARC Food Safety Industrial Transformation Training Centre. Neil’s role in this centre will be to supervise research on the potential for the adoption of modern molecular biology techniques to better understand the risks of microbial contamination throughout the food chain. Neil is passionate about communicating the latest developments in the field of molecular microbiology with people across the food industry, from growers to retailers. He engages directly with farmers on a regular basis, speaking frequently at soil health meetings and field days.

Residence: Australia

Subject: Food-seq: The application of NGS and modern molecular biology techniques in the food industry.